Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

CORRELATION OF METASTASIS AND PROGNOSTIC FACTORS IN SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

두경부 편평세포암종에서 전이와 예후 인자에 대한 연구

  • Seo, Gu-Jong (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Ryu, Sun-Youl (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Kim, Ok-Joon (Department of Oral Pathology, College of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Choi, Hong-Ran (Department of Oral Pathology, College of Dentistry, Dental Science Research Institute, Chonnam National University)
  • 서구종 (전남대학교 치과대학 구강악안면외과학교실, 전남대학교 치의학연구소) ;
  • 유선열 (전남대학교 치과대학 구강악안면외과학교실, 전남대학교 치의학연구소) ;
  • 김옥준 (전남대학교 치과대학 구강병리학교실, 전남대학교 치의학연구소) ;
  • 최홍란 (전남대학교 치과대학 구강병리학교실, 전남대학교 치의학연구소)
  • Published : 2002.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was carried out to evaluate the correlation of metastasis and prognostic factors in squamous cell carcinoma of head and neck. Examination was performed on a series of thirty-seven patients who were confirmed to squamous cell carcinoma and its lymphatic metastasis by pathologist. Correlations of metastasis and other factors such as angiogenesis, histologic grading, and p53 expression and ras oncogene were studied. The depth of tumors was around 1 to 27mm. Twenty cases were more than 10mm deep, of which seventeen cases were shown lymphatic metastasis. Total score of histologic grading including keratinization, nuclear atypia, growth pattern and intensity of inflammation was ranged from 5 to 10 points. Of these factors, nuclear atypia with intensity of inflammation, and nuclear atypia with growth pattern was correlated with nuclear atypia each. For angiogenesis, number of new-formed vessels were counted 13 to 58 each. Twenty-eight cases were shown to lymphatic metastasis. No correlation with histologic grading and lymphatic metastasis was found. The results of immunohistochemical staining for p53 and ras oncogene revealed that positive cases were 16 and 22, negative for 21 and 15 each. However, both were not correlated with histologic grading and lymphatic metastasis. These results were revealed that angiogenesis was not correlated with lymphatic metastasis of squamous cell carcinoma arising in head and neck. Nuclear atypia with intensity of inflammation and dysplasia with growth pattern were correlated with histologic grading, which suggested that more careful and adequate advice is needed for effective treatment.

Keywords

References

  1. Broders AC : Carcinoma; grading and practical application. Arch Pathol 2:376-381, 1926
  2. Ensley JF, Crissman J, Kish J, Jacobs J, Weaver A, Kinzie J : The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer 57:711-717, 1986
  3. Roland JJ, Caslin AW, Nash J, Stell PM : Value of grading squamous cell cardinoma of the head and neck. Head Neck 14:224-229, 1992
  4. Platz H, Fries R, Hudec M, Tjoa AM, Wagner RR : The prognostic relevance of various factors at the time of the first admission of the patient. J Max Fac Surg 11:3-12, 1983
  5. Frierson HF, Cooper PH : Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 17:346-354, 1986
  6. Sugarbaker PH : Cololectal cancer. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer; Principles and Practice of Oncology. Philadelphia, Lippincott. 1985. pp795-884
  7. Jakobsson PA : Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx. Workshop No. 14. In: Alberti PW, Bryce DP, eds. Centennial Conference on Laryngeal Cancer. New York, Appleton-Century-Crofts, 1976. pp847-852
  8. Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squmous cell carcinoma of the oropharynx. Cancer 54:2995-3001, 1984
  9. Bryne M, Koppang HS, Lilleng R, Kjerheim A : Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166:375-381, 1992
  10. Klijanienko J, El-naggar AK, de Braud F, Rodriguez-Peralto JL, Rodriguez R, Itzhaki M, Russo A, Janot F, Luboinski B, Cvitkovic E. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinoma. Cancer 75:1649-56, 1995
  11. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gneco CA, Strong EW. Predictive value of tumor thickness in squamous cell carcinoma confined to the tongue and floor of mouth. Am J Surg 152:345-350, 1986
  12. Cooke LD, Cooke TG, Forester G : Flow cytometric analysis of DNA content in squamous carcinoma of the tongue. Clin Otolaryngol 19:131-134, 1994
  13. Kennedy JC, El-Badawy N, DeRose P. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cyrometric systems. Anal Quant Cytol Histol 14:304-311, 1992
  14. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph nodes prognosis factors in head and neck squamous cell carcinoma. Am J Surg 168:494-498, 1994
  15. Janot F, Klijanienko J, Russo A, Mamet JP, De Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E. Prognostic value of clinocopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br Cancer 73:531-538, 1996
  16. Kearslay JH, Furlong KL, Cooke RA, Waters MJ. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer 61:821-7, 1990
  17. Shingaki S, Suzuki I, Nakajima T, Kawasaki T. Evaluation of histopathologic parameters in predicting cervical lymph node metastasis of oral and oropharyngeal carcinomas. Oral Surg Oral Med Oral Pathol 66:683-8, 1988
  18. Tytor M, Frazen G, Olafsson J. DNA ploidy in oral cavity carcinomas with special reference to prognosis. Head Neck 11:257-63, 1989
  19. Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML, Douc-rasy S, Duvillard P, Armand JP, Riou G : High incidence of p53 alterations(mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10:1217-1227, 1995
  20. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y. Relationship of c-erb-B2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 72:2083-2088, 1993
  21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182, 1987
  22. Logothetis C, Xu H, Ro J, Hue S, Sahin A, Ordonez N, Benedict W. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256-1261, 1992
  23. Pezzella Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Masson DY. Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
  24. Zariwala M, Schmid S. P53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumors and lymph node metastasis. Int J Cancer 56:807-811, 1994
  25. Shin DM, Lee SL, Lippman SM, Lee JJ, Tu NZ, Choi G, Heyne K, Shin HJC, Ro JY, Goepfert H, Hong WK, Hittelman WN. p53 expression; predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 88:519-529, 1996
  26. Bourhis J, Bosq J, Wilson GD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eschwege F : Correlation between p53 gene expression and tumorcell proliferation in oropharyngeal cancer. Int Cancer 57:458-462, 1994
  27. Somers K, Merrick A, Lopez M, Incognito L, Schechter G, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997-6000, 1992
  28. Guerry M, Vabre L, Talbot M, Mamelle G, Leridant AM, Hill C, Bosq J, Luboinski B, Janot F. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma : a case-control study. Br J Cancer 77(11):1932-1936, 1998
  29. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61, 1989
  30. Folkman J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 82:4-6, 1990
  31. Herlyn M, Clark WH, Rodeck U. Biology of tumor progression in human melanocytes. Lab Invest 56:461-474, 1987
  32. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma; a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 22:1205-9, 1986
  33. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediatethickness (0:76-4.0mm thick) skin melanoma. Am J Pathol 133:419-423, 1988
  34. Weidner N, Folkman J, Pozza F. Tumour angiogenesis; a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, 1992
  35. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
  36. Gasparini G, Weidner N, Maluta S. Intratumoral microvessel density and p53 protein; correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55:739-744, 1993
  37. Macchiarini P, Fontanini G, hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1991
  38. Mikami Y, Tsukuda M, Mochimatsu I. Angiogenesis in head and neck tumor. Nippon Jibiinkoka Gakkai Kaiho(J Oto-RhinoLaryngol Soc Japan) 96:645-650, 1993
  39. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373-380, 1994
  40. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 17:312-318, 1995
  41. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 104:724-729, 1995
  42. Gleich LL, Biddinger PW, Pavelic ZP, gluckman JL. Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 18:343-346, 1996
  43. Gleich LL, Biddinger PW, Duperier FD, Gluckman JL. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: A clinical-pathologic correlation. Head Neck 19:276-280, 1997
  44. Leedy DA, Trune Dr, Kronz JD, Weidner N, Cohen JI. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417-422, 1994
  45. Anneroth G, Hansen LS, Silverman S : Malignancy grading in oral squamous cell carcinoma: I. Squamous cell carcinoma of the tongue and floor of the mouth: histologic grading in the clinical evaluation. J Oral Pathol 15:162-8, 1986
  46. Barona de Guzman R, Martorell MA, Basterra J, Armengot M, Alvarez-Valeds R, Garin L : Prognostic value of histopathological parameter in 51 supraglottic squamous cell carcinomas. Laryngoscope 103:538-40, 1993
  47. Bryne M, Koppang HS, Lilleng R, Stene T, Bang, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 18:432-437, 1989
  48. Bryne M, Nielsen K, Koppang HS, Dabelsteen E. Reproducibility of two malignancy grading systems of high prognostic value for oral cancer patients. J Oral Pathol Med 20:369-372, 1991a
  49. Bryne M. Prognostic value of various cellular and molecular features for oral squamous cell carcinomas: a review. J Oral Pathol Med 20:413-420, 1991b
  50. Zatterstrom UK, Wennerberg, Ewers SB, Willen R, Attewell R. Prognostic factors in head and neck Cancer: histologic grading, DNA ploidy, and nodal status. Head Neck 13:477-87, 1991
  51. Bouck N : Tumor angiogenesis: The role of oncogenes and tumor suppressor genes. Cancer Cells 2:179-85, 1990
  52. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
  53. Weinstat-Saslow D, Steeg PS. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401-7, 1994
  54. Chalkey H. Method for the quantitative morphloical analysis of tissues. J Natl Cancer Inst 4:47-53, 1943
  55. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harrist AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, chalkley count, and computer image analysis. J Pathol 177:275-283, 1995
  56. Albo D, Granick MS, Hhala N, Atkinson B, Solomon MP : The relationship of angiogenesis to biological activity in human squamous cell carcinoma of the head and neck. Ann Plast Surg 32:588-594, 1994
  57. Bosari S, Lee AKC, De Lellis RA : Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992
  58. Simpson J, Ahn C, Battifora H, Esteban J. Vascular surface area as a prognostic indicator in invasive breast carcinoma. Lab Invest 70:22A(Abstract)
  59. Traweek ST, Kandalaft PL, Mehta P. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 96:25-31, 1991
  60. Vacca A, Ribatti D, Roncali L. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 72:455-461, 1993
  61. Gasparini G, Weidner N, Bevilacqua P. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466, 1994
  62. Horak Er, Leek R, Klenk N. Angiogenesis assessed by platele/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124, 1992
  63. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55:371-374, 1993
  64. Graeber TG, Osmanian C, Jacks T. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91, 1996